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The hematopoietic system sustains regeneration
throughout life by balancing self-renewal and
differentiation. To stay poised for mature blood pro-
duction, hematopoietic stem cells (HSCs) maintain
low-level expression of lineage-associated genes, a
process termed lineage priming. Here, wemodulated
expression levels of Inhibitor of DNA binding (ID) pro-
teins to ask whether lineage priming affects self-
renewal of human HSCs. We found that lentiviral
overexpression of ID proteins in cord blood HSCs
biases myeloerythroid commitment at the expense
of lymphoid differentiation. Conversely, reducing
ID2 expression levels increases lymphoid potential.
Mechanistically, ID2 inhibits the transcription factor
E47 to attenuate B-lymphoid priming in HSCs and
progenitors. Strikingly, ID2 overexpression also re-
sults in a 10-fold expansion of HSCs in serial limiting
dilution assays, indicating that early lymphoid
transcription factors antagonize human HSC self-
renewal. The relationship between lineage priming
and self-renewal can be exploited to increase expan-
sion of transplantable human HSCs and points to
broader implications for other stem cell populations.
INTRODUCTION
The control of gene expression programs by transcription
factors (TFs) and epigenetic regulators is central to self-renewal,
cell division, and survival of hematopoietic stem cells (HSCs;
Orkin and Zon, 2008). Gradual differentiation into the specialized
cell types of the blood system is directed by lineage-specific TF
networks. Despite their undifferentiated state, HSCs are not
devoid of elements linked to maturation. Rather, activating
epigenetic marks and low-level expression of lineage-associ-
ated genes, a process known as lineage priming, keeps HSCs
responsive to the demands of blood production (Guo et al.,
2013; Hu et al., 1997; Mercer et al., 2011b; Orkin, 2003). This
poised state enables commitment to occur when differentiation
potential for alternative lineages is extinguished. Although there94 Cell Stem Cell 14, 94–106, January 2, 2014 ª2014 Elsevier Inc.is increasing clarity of lineage commitment from a systems
biology perspective, little is known of how lineage priming is
linked to specific HSC fate choices, including self-renewal. A
better understanding of the interplay between TF networks that
regulate stem cell self-renewal and differentiation would
facilitate therapeutically relevant manipulation of stem cells.
For example, bone marrow (BM) transplantation outcomes
(Hofmeister et al., 2007) could be improved by directed dif-
ferentiation to the HSC state or through in vitro expansion of
cord-blood-derived HSCs.
The extent to which lineage-associated TFs regulate HSC
function is highly variable. Whereas the function of Gata1 is
largely restricted to erythroid differentiation (Ferreira et al.,
2005), PU.1 promotes myeloid development when expressed
at high levels while also protecting HSCs from exhaustion
(DeKoter and Singh, 2000; Staber et al., 2013). On the other
hand, several canonical B cell TFs have common features.
E2A, Ebf1, or Pax5 prime HSC for B cell commitment while
also repressing alternative lineage genes (Dias et al., 2008; Lukin
et al., 2011; Nutt et al., 1999). Deficiency in these factors blocks
B cell development and enables expansion of hematopoietic
progenitors with multilineage potential; however, the impact on
self-renewal programs in HSCs has not been established (Table
S1 available online; Ikawa et al., 2004; Mikkola et al., 2002;
Pongubala et al., 2008; Schaniel et al., 2002). Collectively, these
studies suggest that B-lymphoid (hereafter referred to as
lymphoid) commitment is linked to the loss of myeloerythroid
(hereafter referred to as myeloid) potential and HSC homeosta-
sis. Recent high-resolution analysis of the functional properties
and transcriptional programs of human HSCs and various pro-
genitor populations has established that the transition from
HSC to lymphoid progenitors is not binary, but is gradual with
retention of stemness programs up to themultilymphoid progen-
itor (MLP) stage (Laurenti et al., 2013). Despite these advances,
how multilineage gene expression programs and self-renewal
are coordinated within HSCs remains unresolved.
Investigating the impact of commitment programs on stem cell
homeostasis requires the use of a multifunctional regulator. We
looked for genes that (1) regulate multiple TFs, (2) are implicated
in both self-renewal and differentiation, and (3) are differentially
expressed in human HSCs compared to progenitors. The family
of Inhibitor of DNA binding (ID) proteins satisfies these criteria.
First, the ID family consists of four helix-loop-helix (HLH) proteins
(ID1–ID4) that lack a basic DNA-binding domain and inhibit basic
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Figure 1. ID Genes Are Highly Expressed
in Human HSCs and Decrease Early in
Differentiation
(A and B) Sorting scheme to separate stem and
progenitor populations from CB. (A) Abbrevia-
tions, which are used throughout the paper, and
combination of surface markers to isolate CB
cell fractions. (B) Visualization of hierarchical
organization.
(C) Expression of ID family genes in sorted CB
populations. Left panel: HSCs, MPPs, and CPs
were sorted and mRNA levels for ID1, ID2, and ID3
were assessed by qPCR. Absolute expression
relative to GAPDH was calculated using the stan-
dard curve method. The p values are calculated for
HSCs versus CP fractions within gene and HSC
fractions between genes. Results are shown as
mean ± SEM for n = 3 CB. Right panel: ID4 is not
expressed in CB cells. cDNA was generated from
HeLa cells or from CB. Using the primers specified
in Table S2, 40 PCR cycles were run and amplicons
were run on a 3% agarose gel to detect gene
expression.
(D) ID2 expression in highly purified CB
populations. Seven CB fractions were sorted
according to surface marker phenotype and mRNA levels for ID2 were assessed by qPCR. Expression is normalized to the geometric mean of GAPDH and
ACTB. The p values are calculated in comparison to CD49f+ HSC. Results are shown as mean ± SEM of n = 3 CB.
*p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S1.
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specific expression, and both redundant and unique functions
have been attributed to eachmember (Kee, 2009). ID1–ID4 func-
tion by regulating multiple TFs, including the E2A family (Lang-
lands et al., 1997), Tal-1/Scl (Hsu et al., 1994), Rb (Lasorella
et al., 2000), PU.1, andGata1 (Ji et al., 2008). Second, ID proteins
facilitate self-renewal of stem cells in multiple solid tissues (Holl-
nagel et al., 1999; Hong et al., 2011; Jung et al., 2010; Niola et al.,
2012) and tumors (Gupta et al., 2007a; O’Brien et al., 2012). In
mouse hematopoiesis, Id1 but not Id3 deficiency leads to
impaired maintenance of long-term HSCs (Jankovic et al.,
2007; Perry et al., 2007; Suh et al., 2009). Furthermore, Id1-
protein-mediated inhibition of the transcriptional activity of E2A
proteins regulates the balance of myeloid versus lymphoid line-
age commitment (Cochrane et al., 2009). Third, in humans, we
have found that ID1, ID2, and ID3 expression is enriched in
HSCs compared to progenitor cells, but their function has not
been established in human HSCs (Doulatov et al., 2009, 2012;
Notta et al., 2011). The ability of ID proteins to influence multiple
processes provides an attractive entry point to study the regula-
tion of TF networks during HSC self-renewal and differentiation.
Although several studies report HSC defects in Id1-deficient
mice, the function of ID proteins in HSCs is incompletely under-
stood. Enforced Id2 expression has been used to expandmouse
hematopoietic progenitors in vitro and investigate epigenetic
priming of enhancer elements prior to lineage commitment
(Mercer et al., 2011b). Id2 overexpression (OE) promotes prolif-
eration of mousemyeloid progenitors (Li et al., 2010) and impairs
B cell development (Thal et al., 2009). However, mechanistic
insight into the downstream targets through which the different
ID proteins establish their effects in hematopoiesis remains
incomplete. In addition, ID proteins have not been studied in
human HSCs, and findings in mouse HSC biology cannot alwaysbe extrapolated to human HSCs. For example, the surface
phenotype (Larochelle et al., 2011), cycling characteristics
(Catlin et al., 2011), and DNA repair mechanisms (Milyavsky
et al., 2010; Mohrin et al., 2010; Shao et al., 2012) are different
between mouse and human HSCs.
With sensitive xenograft models and advanced sorting
approaches, highly purified humanHSCs and progenitor popula-
tions can be isolated to near clonal purity, enabling accurate
assessment of their transcriptional and functional characteristics
(Doulatov et al., 2010, 2012; Laurenti et al., 2013; Majeti et al.,
2007; Notta et al., 2011). Here, we show that genetic modulation
of ID1, ID2, and ID3 transcriptional regulatory genes as well as
E47 and EBF1 B-lymphoid factors results in perturbation of
HSC transcriptional programs and altered lineage bias.
Reducing lymphoid factors within HSCs led to a marked expan-
sion of transplantable HSCs. Thus, we have uncovered a previ-
ously unrecognized link between differentiation programs and
self-renewal, where priming of lymphoid factors within HSCs
restrains self-renewal.
RESULTS
ID Genes Are Highly Expressed in Human HSCs and
Decrease Early in Differentiation
We carried out gene expression analysis of human HSCs and
progenitor cell populations isolated from lineage-depleted (lin)
cord blood (CB; Figures 1A and 1B) and found that ID1, ID2,
and ID3 are enriched in human HSCs (Doulatov et al., 2009,
2012; Notta et al., 2011). We compared quantities of ID1–ID4
mRNA transcripts by quantitative PCR analysis (qPCR) in the
HSC, multipotent progenitor (MPP), and committed progenitor
(CP) fractions from CB (Figure 1C). ID1 expression was 4-fold
higher in HSCs compared to downstream CP cells. ID2 mRNACell Stem Cell 14, 94–106, January 2, 2014 ª2014 Elsevier Inc. 95
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2.3-fold downregulated in CPs. ID3 showed a trend toward
decreasing expression during differentiation from HSCs to CP
cells. Absolute ID2 expression in the HSC fraction was 3-fold
and 6.5-fold higher than ID1 and ID3, respectively. ID4 transcript
was not detected in CB. These data indicate that expression of
ID1, ID2, and ID3 is higher in HSC fractions compared to down-
stream progenitors and that ID2 expression is higher than its
homologs.
To examine ID2 gene expression in the most refined hemato-
poietic stem and progenitor cell populations, CB was separated
into seven functionally defined cell subsets representing early
stages of lineage commitment (Figures 1A and 1B; Doulatov
et al., 2010; Majeti et al., 2007; Notta et al., 2011). Among
primitive CD34+CD38 populations, ID2 expression was highest
in HSCs and tended to be lower in MPPs (1.7-fold) and MLPs
(1.5-fold) (Figure 1D). In more differentiated CD34+CD38+
CPs, ID2 was significantly downregulated, especially in the
megakaryocyte/erythrocyte progenitor (MEP; 16.3-fold),
followed by the common myeloid progenitor (CMP; 3.1-fold),
granulocyte/macrophage progenitor (GMP; 2.1-fold), and B
and natural killer cell (B/NK) progenitors (1.6-fold; all compared
to CD49f+ HSCs). These data indicate that ID2 is highly
expressed in the most primitive HSC fraction and downregu-
lated early in differentiation.
To evaluate whether ID gene expression is linked to differenti-
ation and loss of stem cell properties, we cultured CB cells in
cytokine-supplemented liquid culture (TSGF6 conditions; see
Experimental Procedures). This caused loss of quiescence and
reduced HSC function as read out by in vivo engraftment poten-
tial (Figures S1A and S1B). Culturing sorted HSCs in TSGF6 con-
ditions resulted in gradual downregulation of ID1 over 14 days:
8.3-fold on day 7 and 16.4-fold on day 14 (Figure S1C). ID2
expression was reduced 1.8- and 1.9-fold after 7 and 14 days
in liquid culture, respectively. The most dramatic changes were
noted in ID3 expression, which was downregulated 20.5-fold
on day 7 and 181.6-fold on day 14. Thus, in HSCs, reduction
of initially high expression levels of ID1, ID2, and ID3 coincides
with loss of quiescence and in vivo repopulating capacity.
ID Family Members Regulate Lineage Differentiation
and Engraftment Levels
High expression of the TF inhibitor ID2 in HSCs suggests it may
be a good target to alter the transcriptional profile and commit-
ment of HSCs. To enable ID2 OE in primary human hemato-
poietic cells to different levels, bidirectional lentiviral OE vectors
were constructed driving ID2 OE from the hPGK or SFFV pro-
moter (P-ID2 and S-ID2), while marking transduced cells with
GFP. Transduction of CB cells with P-ID2 resulted in stable
long-term OE of physiologically relevant levels of ID2 (5.5-fold
higher than endogenous; Figure 2A). As expected, the stronger
SFFV promoter drove ID2 expression to supraphysiological
levels (95-fold), and OE at the protein level was confirmed by
western blot (Figure 2B). Following transduction with P-CTRL
or P-ID2 lentivirus, CB cells were expanded for 10 days in liquid
culture, resulting in similar population doublings (Figure S1D).
Transplantation of sorted GFP+ cells into immunodeficient
mice by limiting dilution analysis (LDA) showed that the percent-
age of engrafted mice and level of engraftment in the BM after96 Cell Stem Cell 14, 94–106, January 2, 2014 ª2014 Elsevier Inc.8.5 weeks were similar between P-CTRL and P-ID2 groups (Fig-
ures 2C and S2A). However, supraphysiological ID2OE by S-ID2
transduction caused a trend toward lower engraftment than
S-CTRL 8.5 weeks after injection (Figure 2D). We also noticed
that the fluorescence intensity of GFP was lower in S-ID2 mice
compared to S-CTRL (Figures 2E and 2F). The mean fluores-
cence intensity (MFI) of GFP strongly correlates with transgene
expression for the bidirectional lentiviral vector that we
employed (Amendola et al., 2005). This suggests that cells
expressing the highest levels of ID2 had a disadvantage during
in vivo repopulation, potentially due to an impaired B cell differ-
entiation. Overall, these findings indicate that modest ID2 OE
does not affect the level of engraftment in primary recipient
mice, whereas supraphysiological expression of ID2 confers a
disadvantage during repopulation.
Modulation of ID gene expression is known to affect lineage
choice in mouse models (Cochrane et al., 2009; Ji et al., 2008;
Thal et al., 2009). To investigate lineage differentiation upon OE
of ID family members, we transduced CB cells with lentiviral
vectors driving ID1, ID2, or ID3OE from the hPGK promoter (Fig-
ures 2A and 2B). Cells were injected after 3 days, and differenti-
ation into CD33+ myeloid and CD19+ lymphoid cells was
assessed in the peripheral blood (PB) and BM of engrafted
mice after 8.5 weeks (Figures S2B and S2C). Consistent with
mouse models, myeloid differentiation was increased and
lymphoid differentiation was decreased by P-ID1, P-ID2, or
P-ID3 transduction. Similar results were obtained for S-ID2 OE
(Figure S2D). We also analyzed long-term (20 weeks) engraft-
ment of P-ID2-transduced CB cells and found increased GlyA+
erythroid differentiation in the BM and a trend toward increased
PB CD3+ T cell engraftment (Figures 2G and 2H). Thus, constitu-
tive expression of ID family members in human CB cells causes
a bias toward myeloid (including erythroid) commitment at the
expense of B-lymphoid differentiation.
Control of Lineage Commitment by ID Family Members
Originates at the Level of HSCs
It was previously shown that retroviral Id2 OE in the mouse
blocks B cell development at the prepro-B cell stage (Thal
et al., 2009). To pinpoint at which stage in the hematopoietic
hierarchy ID genes act to skew lineage differentiation, we
analyzed the phenotypically defined human stem and progenitor
populations from the BM of engrafted mice (Figures 1A and 1B).
Within the transduced CD34+CD38 compartment, P-ID2 and
S-ID2 had similar effects, resulting in a 2.5-fold increase in the
CD45RACD90+ HSC fraction (Figures 3A and 3B). The fre-
quency of MPPs was decreased 3.0-fold and MLPs were
decreased 2.7-fold. Within the committed CD34+CD38+
compartment, P-ID2 and S-ID2 caused a dose-dependent
lineage skewing in favor of CMP/MEPprogenitors at the expense
of B/NK/GMP precursors. These data suggest that a competitive
disadvantage of cells expressing ID2 at the highest levels (Fig-
ures 2E and 2F)may be explained by blockedB cell development
causing impaired engraftment of lymphoid cells. This is reminis-
cent of a differentiation block with highHOXB4OE (Schiedlmeier
et al., 2003) and consistent with the fact that the xenograft sys-
tem requires constant cellular replenishment to maintain high
human cell engraftment due to increased turnover of the B cell
pool (Rossi et al., 2001). Of note, ID1, ID2, and ID3OE had similar
Figure 2. ID Family Members Regulate Lineage Differentiation and Engraftment Levels
(A) Lentiviral OE of ID family genes. P-ID1-, P-ID2-, P-ID3-, and S-ID2-transduced GFP+ CB cells were sorted after 4 days of liquid culture. For P-ID2, linGFP+
HSPCs were also sorted from engrafted mouse BM after 8.5 weeks to test for long-term OE, yielding similar results. The mRNA expression was assessed by
qPCR and normalized toGAPDH. Results are normalized to endogenous levels in CTRL (absolute levels of OE are similar in P-ID1-, P-ID2-, and P-ID3-transduced
cells but higher in S-ID2-transduced cells). Results are shown as mean ± SEM of n = 2–4 CB.
(B) OE of ID family proteins. K562 (ID1 and ID3) or TEX (ID2) cells were transduced with the indicated lentiviruses and protein expression was assessed by
western blot.
(C) Primary LDA in vivo. P-CTRL- or P-ID2-transduced CB cells were expanded for 10 days (Figure S1D). Transduced GFP+ CB cells were sorted and injected at
different doses (the cell number, back-calculated to the day 0 equivalent, is indicated on the x axis). Human cell engraftment was assessed in the BM 8.5 weeks
after transplantation. Every symbol represents one mouse. Line shows median.
(D) Engraftment of S-ID2-transduced CB cells. After 4 day expansion in TSGF6 conditions, transduced GFP+ CB cells were sorted and 250,000 cells
(Experiment 1, left panel) or 215,000 cells (Experiment 2, right panel) were injected. Human cell engraftment was assessed in the BM 8.5 weeks after trans-
plantation. Every symbol represents one mouse. Line shows median.
(E) Representative flow plots are shown of S-CTRL- and S-ID2-transduced CB cells 4 days after transduction (left panel) or isolated from the mouse BM (right
panel). In the BM, S-ID2-transduced CB cells have reduced GFP MFI and display myeloid skewing.
(F) MFI of GFP expression decreases in S-ID2-transduced graft. For statistical analysis, MFI in the human graft after 8.5 weeks was normalized to background
(mouse or GFP cells) and then to MFI before injection. Results of n = 2 CB are pooled; every symbol represents one mouse. Line shows mean ± SEM.
(G and H) Myeloerythroid skewing upon ID2 OE. P-CTRL- or P-ID2-transduced CB cells were injected after overnight transduction. After 20 weeks, the human
CD45+GFP+ graft in the PB and BM was analyzed for CD19 (lymphoid), CD33 (myeloid), CD3 (T cell), and GlyA (erythroid) surface markers. Results are shown as
mean ± SEM of n = 15 mice representing three independent CB samples.
*p < 0.05, **p < 0.01, ****p < 0.0001. See also Figure S2.
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Figure 3. Control of Lineage Commitment by
ID Family Members Originates at the Level
of HSCs
(A and B) ID2 OE alters the phenotype of the HSC
compartment and skews early commitment.
Human HSCs and progenitor cells were isolated
from BM of mice injected with P-CTRL- and P-ID2-
transduced CB (20 weeks) or S-CTRL and S-ID2
(8.5 weeks). (A) Representative flow plots are
shown for P-CTRL- and P-ID2-transduced cells. (B)
Results are shown as mean ± SEM of n = 2–3 CB
samples; P-CTRL and S-CTRLwere combined. The
p value compared to CTRL is shown within bars;
between P-ID2 and S-ID2 is shown above bars.
(C and D) ID2 KD increases HSPC B-lymphoid
commitment. Single shCTRL- or shID2-transduced
HSPCs were sorted onto MS-5 cells in conditions
that allow for myeloid (M: CD14+ or CD11b+), B cell
(B: CD14CD11bCD19+), and NK cell (NK:
CD14CD11bCD56+) differentiation. (C) ID2 KD
efficiency was measured in sorted TagBFP+ cells
by qPCR 6-10 days after transduction. Expression
is normalized to GAPDH. Results are shown as
mean ± SEM for n = 3 CB. (D) Three weeks after
seeding, colony phenotype was assessed by flow
cytometry. Every symbol represents the lineage
readout of 192 single HSPCs; line shows mean of
n = 3 independent CB that are indicated by color.
The p values were calculated using a paired two-
tailed t test (D). For (B) and (C), we used an unpaired
t-test.
*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
See also Figure S3.
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Lymphoid Priming Inhibits Self-Renewaleffects on skewing of lin cells (Figure S3A). Overall, OE of ID
family members alters the distribution of populations throughout
the hematopoietic hierarchy: the proportion of phenotypic HSCs
is increased, and lineage commitment is altered from the earliest
stages of hematopoietic differentiation (MLPs and CMPs)
through to mature cell types.
Commitment of multipotent cells coincides with changes in
transcriptional programs that extend across stem and progen-
itor cell types (Laurenti et al., 2013). Accordingly, lineage-asso-
ciated factors are expressed at low levels in HSCs to allow for
rapid commitment (Doulatov et al., 2009; Hu et al., 1997; Orkin,
2003; Orkin and Zon, 2008). To test whether ID2 functions to
restrain expression of B-lymphoid factors in uncommitted pro-98 Cell Stem Cell 14, 94–106, January 2, 2014 ª2014 Elsevier Inc.genitor cells, we performed single-cell
analysis of hematopoietic stem and pro-
genitor cell (HSPC) capacity to differen-
tiate into myeloid, B-, and NK cells using
our stromal coculture assay system
(Doulatov et al., 2010; Laurenti et al.,
2013). Reducing ID2 expression levels
by 35% using lentiviral short hairpin
RNA (shRNA) expression (Figure 3C)
consistently increased HSPC commit-
ment to the B cell fate at the single-cell
level (6.7 ± 0.2% increase; Figures 3D
and S3B). As well, OE of the B-lymphoid
factor E47 in HSPCs caused a trend
toward increased B cell differentiation ofsingle HSPC (6.1 ± 1.8% increase; Figures S3C and S3D).
These data indicate that ID2 functions in human HSPCs to
restrain expression of B-lymphoid factors and balance lineage
commitment.
Attenuated Lymphoid Priming and Enrichment of
Myeloid and Stemness Programs in ID2 OE HSPCs
To investigate possible mechanisms underlying myeloid
skewing and expansion of phenotypic HSCs upon ID2 OE,
we performed global gene expression analysis on HSPCs iso-
lated from the BM of mice 8.5 (CB1 and CB2) or 20 weeks
(CB3) after transplantation of P-CTRL- or P-ID2-transduced
CB cells. To assess the effect of ID2 OE on HSC- and
AB
C D
Figure 4. Attenuation of Lymphoid Priming
and Enrichment of Myeloid Programs in ID2
OE HSPCs
(A and B) P-ID2 gene expression profile demon-
strates (A) positive enrichment with GMP and (B)
negative enrichment with pro-B-cell (ProB, CD34+
CD19+CD10+) gene signatures. GSEA is shown on
the left, and heatmap of leading edge genes is
shown on the right, with important lineage-associ-
ated factors highlighted.
(C) TF binding site overrepresentation in the 250
most downregulated genes upon ID2OEwas tested
using the oPOSSUM algorithm (Ho Sui et al., 2005).
Top ten TFs that are predicted to be inhibited by ID2
are shown. Note that ID proteins bind E proteinswith
high affinity but not TAL1/SCL (Langlands et al.,
1997).
(D) GSEA analysis was performed to test for
enrichment of PU.1ki/ki, E47/, E2A/, Foxo1/,
Ebf1/, Pax5/,Rb triple knockout and TAL1/SCL
gene signatures in human ID2OEHSPCs (Table S1).
Rb and TAL1/SCL did not show enrichment, with a
cutoff of false discovery rate (FDR) q value < 0.01.
NES, normalized enrichment score; p, nominal
p value.
See also Table S1 and Figure S4.
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gene set enrichment analysis (GSEA) using signatures gener-
ated from purified HSCs and progenitor fractions from CB
(Laurenti et al., 2013). The HSC gene signature was modestly
enriched in the ID2 OE gene expression profile (Figure S4A).
The myeloid GMP, CMP, and MEP precursor signatures were
highly enriched in ID2 OE HSPCs (Figures 4A and S4A). This
overrepresentation was partly driven by enhanced expression
of myeloid TFs such as CEBPA, PU.1, and GATA1 upon ID2
OE. Conversely, the pro-B-cell gene signature was negatively
enriched in the ID2 OE gene expression profile, with accompa-
nying downregulation of canonical B cell factors (Figure 4B).
Enrichment of B cell TF binding sites was found in genes
that were downregulated upon ID2 OE (Figure 4C). Further
support for reduced B-lymphoid priming came from GSEA
with loss-of-function mouse models; the strongest correlation
was found between ID2 OE HSPCs and the mouse E47/
HSCs (Figures 4D and S4B; Table S1; Yang et al., 2011).
The E2A splice variants E12 and E47, known binding partners
of ID family genes, induce expression of EBF1 and FOXO1 in a
triad responsible for the initiation of B cell development (Lin
et al., 2010; Mercer et al., 2011a). Taken together, our findings
demonstrate that ID2 OE in human HSPCs increases ex-
pression of stem cell and early myeloid differentiation pro-
grams and reduces expression of B cell factors, including
EBF1 and FOXO1, possibly through attenuating the activity
of the TF E47.Cell Stem Cell 14, 94–Lymphoid Transcription Factors
Antagonize Human HSC
Maintenance In Vivo
We next investigated whether the changes
in HSPC phenotype upon enforced ID2
expression are mediated through the inter-action between ID2 and E2A proteins. Absolute mRNA levels of
E12 and E47 were similar in HSC-enriched CD34+CD38 cells,
CD34+CD38+ CPs, and CD34 fractions isolated from CB (Fig-
ure 5A), with no apparent differential expression during early
commitment. Expression of E12 and E47 did not change in
P-ID2-transduced human HSPCs sorted from mouse BM;
however, their transcriptional targets EBF1 and FOXO1 were
downregulated (1.9- and 1.7-fold lower, respectively; Figure 5B).
To provide genetic evidence that ID2 functions through inhibition
of E47 activity in human HSPCs in vivo, we transduced CB cells
with GFP-marked P-ID2 and at the same time with a TagBFP-
marked P-CTRL or TagBFP-marked P-E47 lentiviral vector. As
expected, 8.5 weeks after transplantation of transduced cells
into mice, P-ID2 caused an increased percentage of HSCs
compared to nontransduced and P-CTRL-transduced cells (Fig-
ures 5C and 5D). In contrast, the percentage of HSCs was back
to normal levels in P-ID2/P-E47 double-transduced cells. The
rescue of the ID2 OE phenotype by simultaneous E47 OE con-
firms that HSC expansion upon ID2 OE is in part mediated by
functional inhibition of E47.
We next wanted to determinewhether increased expression of
E47 alone would have the opposite effect of ID2OE. We injected
CB cells that were transduced with P-CTRL (marked by GFP)
and P-E47 (marked by TagBFP) in competitive repopulation
assays. After 8.5 weeks, the frequency of human stem and pro-
genitor cells in engraftedmicewas analyzed. TheHSC frequency
was decreased 2.4-fold upon E47 OE (Figure 5E). As well, E47106, January 2, 2014 ª2014 Elsevier Inc. 99
Figure 5. Lymphoid TFs Antagonize Human
HSC Maintenance In Vivo
(A) E2A family gene expression in sorted CB pop-
ulations. Absolute mRNA levels for E12 and E47
were assessed by qPCR in four CB populations
sorted based on CD34 and CD38. Absolute
expression relative to GAPDH was calculated
using the standard curve method. Results are
shown as mean ± SEM for n = 3 CB.
(B) Regulation of canonical B cell factors by ID2.
Decreased expression of EBF1 and FOXO1 in
P-ID2-transduced human HSPCs sorted from en-
grafted mice, as assessed by qPCR. Expression is
normalized to the average of P-CTRL and to
GAPDH. Statistical analysis was performed by
paired two-tailed t test. Results are shown as
mean ± SEM for n = 3 CB.
(C and D) Double transduction with P-ID2 and
P-E47 rescues HSPC compartment phenotype.
CB cells were transduced with GFP-marked P-ID2
and TagBFP-marked P-CTRL or P-E47 OE vec-
tors. Cells were injected and, after 8.5 weeks, hu-
man linCD45+ cells were analyzed by cell surface
marker expression. (C) Representative flow plots
are shown. (D) Percentage of CD45RACD90+
cells within linCD45+CD34+CD38 compartment.
P-CTRL and nontransduced data are pooled for
CTRL. Results are shown as mean ± SEM for n = 3
CB; some data points were excluded when not
enough events were recorded.
(E) E47 OE impairs maintenance of phenotypic
HSCs in vivo. CB cells were transduced with
P-CTRL or P-E47 vectors and injected. After
8.5 weeks, mice were sacrificed and the frequency
of stem and progenitor cell populations within the
human linCD45+ graft was determined. Gating
was similar to Figure 3A. Results are shown as
mean ± SEM for n = 3 CB.
(F) EBF1KD blocks B cell differentiation. shLUC- or
shEBF1-transduced CB cell engraftment was
assessed 10 weeks after transplantation. Highly
transduced cells within the human CD45+ graft
showed a strong decrease in CD19+ B cell differ-
entiation. Results are shown as mean ± SEM of n =
10 mice representing two independent CB sam-
ples (Experiment 1 and Experiment 3 shown in (G)).
(G and H) EBF1 KD increases phenotypic HSC
frequency. (G) Left panel: EBF1 KD efficiency was
measured by qPCR 4 days after transduction
(GFP+ cells were not sorted since transduction
was >80%); expression is normalized to GAPDH;
results are shown asmean ± SD for n = 2 technical duplicates. Right panel: Ten weeks after injection, the human linCD45+ graft was analyzed by flow cytometry;
gating within the GFPhiCD34+CD38 compartment is shown for three independent CB samples. (H) Frequency of human stem and progenitor cells in shLUC and
shEBF1 BM. Results are shown as mean ± SEM for n = 2 CB (Experiment 1 and Experiment 3).
*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
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CMP/MEP progenitors. These data suggest that E47 acts early
in the human hematopoietic hierarchy and has a negative impact
on humanHSCmaintenance in vivo as predicted from the ID2OE
studies.
The E2A and EBF1 genes are similar in that they are required
for B cell development (Bain et al., 1997; Lin and Grosschedl,
1995). As well, deficiency of either factor enables in vitro expan-
sion of mouse multipotent progenitors (Ikawa et al., 2004;
Pongubala et al., 2008; Table S1). To investigate whether B cell100 Cell Stem Cell 14, 94–106, January 2, 2014 ª2014 Elsevier Inc.lineage priming in general, rather than just the ID2-E47 interac-
tion, can have an effect on HSCs, we transduced CBwith shLUC
or shEBF1 knockdown (KD) vectors. As predicted by mouse
models, EBF1 KD resulted in reduced CD19+ B cell engraftment
(Figure 5F). Interestingly, EBF1 KD also partially phenocopied
ID2 OE, as there was a 2.1-fold increase in the frequency of
HSCs (after excluding one sample with poor KD; Figures 5G
and 5H). We did not find a difference in the frequency of B/NK/
GMP versus CMP/MEP progenitors, suggesting that EBF1 KD
may act at a later stage to block B cell commitment. Taken
Figure 6. Increased Number and Frequency of Functional HSCs In Vivo
(A) Increased absolute number of HSPCs upon ID2 OE. Absolute number of lin GFP+CD34+CD38CD45RA cells isolated from P-ID2-injected BM was
normalized to injected cell number and to P-CTRL within each experiment. Results are shown as mean ± SEM for n = 6 CB. *p < 0.05.
(B) Experimental design to compare the self-renewal capacity of P-CTRL- and P-ID2-transduced CB cells.
(C and D) Secondary LDA in vivo. P-CTRL- or P-ID2-transduced GFP+ cells were sorted from primary xenografts (Figure 2C) and injected in limiting doses,
indicated on the x axes. After 8.5 weeks, BM was assessed for human engraftment. (C) Every symbol represents one mouse. (D) Pooled data from two ex-
periments are shown; frequency statistics are calculated with ELDA software.
(E) Expansion of P-ID2-transduced HSCs during primary transplantation. Calculations are based on primary LDA and secondary LDA as outlined in (B). The
o symbol indicates back-calculated to day 0 equivalent. The * indicates that these numbers are restricted to the mice that were selected for serial transplantation.
(F and G) In secondary transplantations, P-ID2-transduced CB cells give multilineage engraftment. (F) Representative flow plots. (G) Bar graphs show percentage
of myeloid (CD33+) and lymphoid (CD19+) cells in P-CTRL and P-ID2 derived human CD45+ graft. Every bar represents one mouse. Data from two experiments
shown in (C) are pooled.
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increased proportion of phenotypic HSCs upon ID2 OE is medi-
ated by attenuated B-lymphoid priming.
Attenuation of Lymphoid Priming Increases the
Absolute Number and Frequency of Functional HSCs
In Vivo
The proportional increase in phenotypically defined HSCs
observed upon ID2 OE was accompanied by an average 2.2-Cfold increase in the absolute number of phenotypic HSPCs (Fig-
ure 6A). To determine whether these increases coincided with an
absolute increase in the number of functional HSCs, human
CD45+GFP+ cells were isolated by flow cytometry from
P-CTRL- and P-ID2-engrafted mice 8.5 weeks after transplanta-
tion. In two independent LDA experiments, secondary recipient
mice were injected with doses ranging from 150,000 to
600,000 cells, and engraftment was assessed after 8.5 weeks
(Figure 6B). Engraftment of P-CTRL-injected mice was onell Stem Cell 14, 94–106, January 2, 2014 ª2014 Elsevier Inc. 101
Figure 7. Inhibition of Lymphoid Priming
Increases HSC Self-Renewal
Under normal circumstances, HSC priming is
balanced by low-level expression of myeloid and
lymphoid-associated genes. Inhibition of E47
activity by ID2 OE attenuates initiation of a
B-lymphoid program. In turn, myeloid (including
erythroid) as well as stemness programs are
upregulated in HSCs. This leads to a myeloid
differentiation bias, increased self-renewal, and
an expansion of phenotypic and functional HSCs
in vivo.
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showed an average 1.1% engraftment (Figure 6C). Importantly,
the number of engrafted mice was also changed: 3 out of 12
P-CTRL mice were positive, while 11 out of 12 P-ID2 mice
were engrafted, demonstrating by LDA that there was an
11-fold increase in the number of self-renewing HSCs upon
ID2 OE (Figure 6D). Since both primary and secondary LDA
was performed, we were able to determine that the number of
HSCs generated during repopulation of primary mice remained
stable for P-CTRL-transduced cells (average 0.93-fold expan-
sion), while for P-ID2-transduced cells there was an average
9.8-fold expansion of HSCs (Figure 6E). Almost all mature cells
in secondary P-CTRL-derived grafts were B cells, with few
myeloid cells detected (Figures 6F and 6G). In contrast, the sec-
ondary BM graft derived from P-ID2-transduced cells contained
both lymphoid and substantial myeloid engraftment. Thus, our
data indicate that attenuation of lymphoid priming expands the
number of HSCs that retain self-renewal capacity in vivo.
DISCUSSION
Our findings establish that lymphoid lineage priming acts in
HSCs to restrain self-renewal, providing insight into the coordi-
nation of lineage and stem cell gene expression programs during
the gradual transition from HSCs to committed progenitor cells
(Figure 7). The classical hierarchical model attributes the prop-
erty of self-renewal solely to the stem cell at the apex of the
hierarchy with rapid loss when commitment occurs. However,
our data indicate a more complex interplay between lineage-
associated programs and self-renewal. As a tool to study this
interaction, we used ID2 OE to attenuate lymphoid priming
through E47 inhibition. Concomitant to this attenuation, both
stemness and myeloid-associated programs were enhanced
within HSCs, yielding a marked increase in the number of func-
tional HSCs with a myeloid differentiation bias. Historically, the
Waddington landscape of development predicts that blocking
differentiation into one lineage would result in the choice of an102 Cell Stem Cell 14, 94–106, January 2, 2014 ª2014 Elsevier Inc.alternative differentiation path. According
to this model, preventing lymphoid
commitment in our experimental setting
should have resulted only in increased
myeloid output, yet HSC self-renewal
was profoundly affected. Furthermore,
our data are consistent with recent
studies that point to the gradual loss ofself-renewal during early lymphoid commitment (Laurenti et al.,
2013), as well as an observed decline in HSC number when
lymphoid commitment is enhanced (Oguro et al., 2010). Thus,
our data uncover a process that links lineage-associated TF
networks with stemness.
We identify ID and E proteins as important factors that control
the transcriptional state of HSCs. ID family members, especially
ID2, are highly expressed in human HSCs, inhibit the transcrip-
tional activity of E47, and thereby repress E47 targets such as
EBF1 and FOXO1. By performing ID2 KD we show that this con-
trol of lymphoid factor priming is important for balanced lineage
commitment at the level of single HSCs. The ID2/E2A axis was
recently manipulated to investigate epigenetic establishment of
transcriptional networks during HSC commitment in the mouse
(Mercer et al., 2011b). In conjunction with our work, this suggests
that ID2 downregulation during differentiation represents a
conserved mechanism that facilitates further transcriptional
and epigenetic changes. By releasing restraints on lymphoid
commitment, stemness and myeloid programs are lost and
lymphopoiesis proceeds. Thus, the reciprocity between ID2
and E47 occupies a central role in the appropriate expression
of lymphoid, myeloid, and self-renewal factors in HSCs.
The downregulation of lymphoid priming and coinciding upre-
gulation of myeloid and stemness genes we found with ID2 OE
are reminiscent of the changes that normally occur during aging.
Downregulation of lymphoid genes and upregulation of myeloid
genes are seen during normal aging and cause diminished
lymphoid lineage differentiation in favor of myeloid differentiation
(Pang et al., 2011). The age-related lineage biases may be due to
expansion of a subset of myeloid-biased HSCs rather than
changing properties of a homogeneous pool of HSCs (Muller-
Sieburg et al., 2012). The diminution of self-renewal by priming
of lymphoid factors we observe may also occur during aging,
thereby contributing to the dominance of myeloid-biased
HSCs. An interesting question for future investigation re-
mains whether the increased myeloid program in the human
HSC compartment upon ID2 OE is due to HSCs intrinsically
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biased subset of HSCs.
Constitutive ID2 expression in CB cells causes an increase in
the percentage and absolute number of phenotypic human
HSCs in vivo, as well as a 10-fold expansion of HSCs capable
of secondary repopulation. This effect is considerable compared
to previously reported human HSC expansion using genetic
approaches by constitutive expression of HOXB4 or NOV, or
knockdown of miR-126. Nongenetic methods for human HSC
expansion include inhibitory feedback signaling control and
exposure to aryl hydrocarbon receptor antagonists, Notch ligand
Delta1, or Prostaglandin E2 (Csaszar et al., 2012; Dahlberg et al.,
2011; Gupta et al., 2007b; Lechman et al., 2012). Combining
thesemethodswith targeted perturbation of the gene expression
modulation that ID2 causes, for example by recombinant protein
addition or E47 inhibition, may lead to improved methods to
expand CB-derived HSCs for clinical use.
Complex transcription factor interactions occur during differ-
entiation (May et al., 2013). E2A and Pax5 have been linked to
repression of non-B-cell genes (Ikawa et al., 2004; Lukin et al.,
2011; Nutt et al., 1999), and Ebf1 downregulates Id2, Id3, and
Cebpa through direct transcriptional repression (Nechanitzky
et al., 2013; Pongubala et al., 2008; Thal et al., 2009). As well,
the stem cell factor Bmi1 epigenetically represses Ebf1 and
Pax5, contributing to HSC multipotency by postponing lineage
specification (Oguro et al., 2010). Our data, when taken into
the context of these studies, suggests that repression of
stemness by lineage priming programs provides a paradigm
that should focus future research on uncovering whether similar
processes are present in different tissue hierarchies.
EXPERIMENTAL PROCEDURES
CB Lineage Depletion and Lentiviral Transduction
CB samples were obtained from normal full-term deliveries after informed
consent, according to procedures approved by the institutional review boards
of the University Health Network and Trillium Hospital. Mononuclear cells were
obtained by density gradient centrifugation on Ficoll. Stem and progenitor
cells were enriched by lineage depletion using the StemSep Human Progenitor
Cell Enrichment Kit according to the manufacturer’s protocol (StemCell
Technologies). Lineage-negative CB cells (referred to as CB, 50%–75%
CD34+) were stored at 150C. For transduction, CB cells were thawed and
plated in X-VIVO (BioWhittaker) supplemented with 1% BSA, 2 mM
L-glutamine, and 100 U/mL penicillin-streptomycin (P/S). Concentrated
lentiviral particles were resuspended in the same medium and added to cells
at a multiplicity of infection (MOI) of 5–50. The mixture was then supplemented
with 15 ng/mL TPO, 100 ng/mL SCF, 10 ng/mL G-CSF, 100 ng/mL Flt3-L, and
10 ng/mL IL-6 for a minimum of 16 hr. Subsequent expansion was performed
in the same medium with half the concentration of these cytokines, referred to
as TSGF6 culture.
Mouse Xenotransplantation and Human Lin– Cell Isolation
Animal work was carried out in compliance with the ethical regulations
approved by the Animal Care Committee, University Health Network (Toronto,
ON, Canada). Mouse xenografts were performed as described previously
(Lechman et al., 2012; McDermott et al., 2010). Briefly, male nonobese
diabetic/Lt-scid/IL2Rɣnullmice were sublethally irradiated (225 cGy) 1 day prior
to injection. Transduced cells were injected with 30 ml PBS into the right femur
of recipient mice. After euthanizing mice, bones were flushed or crushed in
2 ml PBS 2% fetal calf serum (FCS), and 50 ml was stained with antibodies
to surface markers. The remaining cells were enriched for human lin cells
for additional surface marker analysis, sorted for secondary transplants, or
used for microarray analysis. Enrichment of human lin cells was performedCby depletion of all mouse and lineage-positive human cells, as described
previously (Lechman et al., 2012).
Secondary Limiting Dilution Analysis
LDA of human CB cells in secondary recipient mice was performed by sorting
human CD45+GFP+ cells from pooled BM of primary mice 8.5 weeks after
transplantation and injection of 150,000 to 600,000 cells into secondary
recipients. A secondary mouse was scored as positive if it had >0.01%
human BM engraftment 8.5 weeks after transplantation. HSC frequency was
estimated using the ELDA software (Extreme Limiting Dilution Analysis,
http://bioinf.wehi.edu.au/software/elda/; Hu and Smyth, 2009).
Lentiviral Vectors
The bidirectional MA1 vector, provided by Dr. Luigi Naldini (Amendola et al.,
2005), was used for OE studies.DNGFRwas replaced by (1) humanizedRenilla
Luciferase or a Stuffer sequence derived from pLKO.1_1.9Kb_stuffer for
P-CTRL; (2) ID1 cDNA from the Mammalian Gene Collection through the
PlasmID Repository at Harvard for P-ID1 (clone ID HsCD00043310); (3) ID2
cDNA from PlasmID for P-ID2 (clone ID HsCD00042875); (4) ID3 cDNA
obtained from HeLa cDNA by PCR amplification for P-ID3, and (5) E47
cDNA obtained from Addgene Plasmid 16059 by PCR amplification for
P-E47. The hPGK promoter driving transgene expression was replaced by
the SFFV promoter (Gentner et al., 2009) for S-ID2 and S-CTRL. GFP was
replaced by TagBFP (Evrogen; Subach et al., 2008) for P-E47 and TagBFP-
marked P-CTRL. For KD, shCTRL and shID2 were made by replacing
mOrange with TagBFP and miR-126 with hairpins targeting Luciferase or ID2
(CCCTTCTGAGTTAATGTCAAA) in the previously described 126/OE vector
(Lechman et al., 2012). The shLUC and shEBF1 knockdown vectors, pLKO
with U6 driving hairpin expression and GFP instead of puromycin resistance,
were described previously (Laurenti et al., 2013).
Cell Sorting
After thawing, human CB cells were resuspended at 107 cells/mL and stained
for surface markers in PBS with 2% FCS. Cells were sorted on the BD FACS
Aria or on a MoFlo sorter (DAKO), consistently yielding >95% purity. The
following anti-human antibodies were used for sorting: CD34-APC7 (BD,
custom made), CD38-PC7 (BD, catalog no. 335790), CD90-PE (BD, catalog
no. 555596), CD45RA-FITC (BD, catalog no. 555488), CD49f-PC5 (BD, catalog
no. 551129), CD10-APC (BD, catalog no. 340923), CD135-PE (BD, catalog no.
558996), and CD7-PC5 (Coulter, catalog no. IM3613U).
Quantitative RT-PCR
RNAwas extracted from cells using TRIzol and resuspended in water for cDNA
synthesis using the SuperScript III or SuperScript VILO system (Life
Technologies). Quantitative RT-PCR was performed in the presence of Power
SYBR Green using a 7900 HT real-time PCR system (Applied Biosystems).
Primer sequences are listed in Table S2. Absolute expression (relative to
GAPDH) was determined using a standard curve with known amplicon quan-
tity when indicated in the figure caption. Otherwise, y axis values are arbitrary.
Western Blot
Transduced K562 or TEX cells (Warner et al., 2005) were lysed, separated with
SDS-PAGE, and transferred as reported previously (O’Brien et al., 2012). ID
antibodies were purchased from Santa Cruz (sc-488, sc-489, and sc-490).
Clonal Analysis of HSPC Lineage Potential
MS-5-myeloid-cell-B-cell-NK-cell assay was performed as described
previously (Laurenti et al., 2013). Briefly, CB cells were transduced overnight.
The next day, single CD34+CD38CD45RA HSPCs were sorted onto MS-5
stromal cells in H5100 medium (StemCell Technologies) supplemented with
P/S, L-glutamine, and the following cytokines: 100 ng/mL SCF, 10 ng/mL
Flt3-L, 50 ng/mL TPO, 10 ng/mL IL-2, 20 ng/mL IL-7, 20 ng/mL IL-6,
20 ng/mL G-CSF, and 20 ng/mL GM-CSF (all from R&D Systems). Half the
medium was changed weekly. Three weeks after seeding, PICD45+TagBFP+
colony cells were assessed for expression of myeloid (>100 CD11b+ or
CD14+ cells), B cell (>10 CD11bCD14CD19+ cells), or NK cell (>10
CD11bCD14CD56+ cells) markers by flow cytometry.ell Stem Cell 14, 94–106, January 2, 2014 ª2014 Elsevier Inc. 103
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RNA extraction, cDNA synthesis, and pre-Amplification were carried out as
previously described (Fan et al., 2012). Whole-genome gene expression
analysis was performed using the Whole-Genome DASL HT assay, which
interrogates 29K targets corresponding to 21K genes (April et al., 2009).
Data were quantile normalized (‘‘normalizeQuantiles’’ command from the
limma package; version 3.6.9) and then log2-transformed. All subsequent
analyses were carried out with this data set (Gene Expression Omnibus
[GEO] access code GSE45486). Differential expression tests were performed
with the limmapackage (version 3.6.9; Smyth, 2004). Geneswere sorted based
on the fold-change between P-CTRL and P-ID2 for prerankedGSEAwith 1,000
permutations (Subramanian et al., 2005). Signatures of the top 250 genes that
are highest in stem and progenitor cells were used as gene sets to test for
enrichment (Laurenti et al., 2013). For transcription factor binding site enrich-
ment analysis, Single Site Analysis was performed using oPOSSUM algorithm
version 3.0 (http://opossum.cisreg.ca/oPOSSUM3/) with the 250 most
downregulated genes upon ID2 OE in 1,000/500 upstream/downstream
basepairs around transcription start sites (Ho Sui et al., 2005).
Statistical Analysis
Unless otherwise stated, two-tailed unpaired Student’s t test was used to
determine significance and mean ± SEM values are reported in the graphs.
Supplemental Materials
Table S1 describes relevant mouse models and gives the source of signatures
for GSEAwith ID2OE. Table S2 lists the qPCR primers used in this study. Table
S3 lists ID2 OE HSPC array results ranked by fold change. Figure S1 shows
changes that occur upon expansion of CB cells in TSGF6 culture conditions.
Figure S2 contains analyses of P-ID1-, P-ID2-, P-ID3-, and S-ID2-transduced
CB cells in vivo. Figure S3 shows support for altered progenitor phenotype and
lineage potential upon ID1, ID2, and ID3 and E47 modulation. Figure S4
contains additional GSEA plots.
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